WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co. Inc. today announced the winners of the second annual Merck Index Women in Chemistry Scholarship program. The program is designed to foster support for women choosing to pursue advanced degrees in medicinal or synthetic organic chemistry.
"We are pleased to be role models for these exceptional young women," said Maryadele J. O'Neil, Editor of The Merck Index. "This program allows us to encourage them in a tangible way and underscores Merck's commitment to workplace diversity as well as excellence in science and education."
The awards will be presented on Monday, Aug. 18, as part of The Merck Index Women in Chemistry Awards Symposium and Poster Session, being held at the American Chemical Society 236th National Meeting and Exposition in Philadelphia. The introductory address will be given by Dr. Mervyn J. Turner, Senior Vice President, Worldwide Licensing and External Research, Merck Research Laboratories. Dr. Turner will speak on “The Challenges of Bringing Drugs to Patients in the 21st Century.”
The five award recipients will each receive a $5,000 scholarship and present their undergraduate research at the symposium. The award winners are: Karen Brown, Harvey Mudd College; Sarah Goforth, Furman University; Sandra M. King, Grinnell College; Chawita Netirojjanakul, MIT; and Amy Tremblay, Carleton University.
Closing the symposium will be Dr. Renata Oballa, Senior Research Fellow, Merck Frosst Canada, who will discuss her transformation “From Organic Chemist to Drug Discovery Scientist: A Career in Osteoporosis Research.”
An additional ten students will present their research at the poster session and will receive special recognition awards in the form of a travel grant. These students are: Kristen Clary, University of Calgary; Anna Dawsey, College of Charleston; Maggie He, City College of New York; Casie Hilliard, University of Florida; Lauren Martini, NYU; Alison Oostendorp, Elmhurst College; Caroline Proulx, University of Ottowa; Lindsay Repka, Barnard College; Kelly Volp, University of Kansas; and Christina Woo, Wellesley College.
The Merck Index Women in Chemistry Scholarship program is administered by the editorial staff of The Merck Index, Chemistry's Constant Companion®. The application deadline for the 2009 scholarship program is March 15, 2009. Detailed award criteria and application forms are available on The Merck Index website at: www.merckbooks.com/mindex.
About The Merck Index
With more than 1 million copies sold, The Merck Index has been the go-to reference for generations of professionals looking for precise, comprehensive information on chemicals, drugs, and biologicals. First published in 1899, this publication predates The Merck Manual and is the most widely used text of its kind. Merck publishes all of the Merck manuals as a service to the community. All have strict editorial independence, do not include any marketing information or promote any pharmaceutical medicines. The manuals are available free in multiple languages at www.merckbooks.com.
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.
This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the risk factors and cautionary statements in Item 1A of Merck's Form 10-K for the year ended Dec. 31, 2007, and in any risk factors or cautionary statements contained in the Company's periodic reports on Form 10-Q or current reports on Form 8-K, which the Company incorporates by reference.